 Vaccines, Virus-Like Particle
"Vaccines, Virus-Like Particle" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines using supra-molecular structures composed of multiple copies of recombinantly expressed viral structural proteins. They are often antigentically indistinguishable from the virus from which they were derived.
| Descriptor ID |
D058425
|
| MeSH Number(s) |
D12.776.828.868.955 D20.215.894.865.955 D23.050.865.955
|
| Concept/Terms |
Vaccines, Virus-Like Particle- Vaccines, Virus-Like Particle
- Particle Vaccines, Virus-Like
- Vaccines, Virus Like Particle
- Virus-Like Particle Vaccines
- Virus Like Particle Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Virus-Like Particle".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Virus-Like Particle".
This graph shows the total number of publications written about "Vaccines, Virus-Like Particle" by people in this website by year, and whether "Vaccines, Virus-Like Particle" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vaccines, Virus-Like Particle" by people in Profiles.
-
Beck SE, Queen SE, Viscidi R, Johnson D, Kent SJ, Adams RJ, Tarwater PM, Mankowski JL. Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control. J Neurovirol. 2016 08; 22(4):498-507.
-
Wahome N, Cooper A, Thapa P, Choudhari S, Gao FP, Volkin DB, Middaugh CR. Production of Well-Characterized Virus-like Particles in an Escherichia coli-Based Expression Platform for Preclinical Vaccine Assessments. Methods Mol Biol. 2016; 1404:437-457.
-
Wahome N, Hickey JM, Volkin DB, Middaugh CR. Formulation Studies During Preclinical Development of Influenza Hemagglutinin and Virus-Like Particle Vaccine Candidates. Methods Mol Biol. 2016; 1404:393-421.
-
Van Damme P, Leroux-Roels G, Simon P, Foidart JM, Donders G, Hoppenbrouwers K, Levin M, Tibaldi F, Poncelet S, Moris P, Dessy F, Giannini SL, Descamps D, Dubin G. Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials. Vaccine. 2014 Jun 17; 32(29):3694-705.
-
Rosenthal JA, Chen L, Baker JL, Putnam D, DeLisa MP. Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale. Curr Opin Biotechnol. 2014 Aug; 28:51-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|